These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15518443)

  • 1. Review: lactulose or lactitol may improve hepatic encephalopathy but may be less effective than antibiotics.
    Korula J
    ACP J Club; 2004; 141(3):59. PubMed ID: 15518443
    [No Abstract]   [Full Text] [Related]  

  • 2. Review: rifaximin is equally or more effective than other antibiotics and lactulose for hepatic encephalopathy.
    Alcorn J
    ACP J Club; 2008 Nov; 149(5):11. PubMed ID: 19014178
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nightly high dose lactulose infusion could be a cost-effective treatment for hepatic encephalopathy, renal insufficiency and heart failure.
    Alisky JM
    Med Hypotheses; 2007; 69(1):6-7. PubMed ID: 17467192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy.
    Sharma P; Sharma BC; Puri V; Sarin SK
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):506-11. PubMed ID: 18467909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of antibiotics in the management of hepatic encephalopathy.
    Maddrey WC
    Rev Gastroenterol Disord; 2005; 5 Suppl 1():S3-9. PubMed ID: 15976746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P; Sharma BC; Sarin SK
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo.
    Sharma BC; Sharma P; Agrawal A; Sarin SK
    Gastroenterology; 2009 Sep; 137(3):885-91, 891.e1. PubMed ID: 19501587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Confusion and abnormal liver enzyme levels: problems with diagnosing hepatic encephalopathy].
    Hendriks ME; van Westerloo DJ; Portegies P
    Ned Tijdschr Geneeskd; 2007 Dec; 151(49):2701-6. PubMed ID: 18225787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic encephalopathy: pathophysiology and advances in therapy.
    Av SP
    Trop Gastroenterol; 2007; 28(1):4-10. PubMed ID: 17896602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic treatment of chronic hepatic encephalopathy with rifaximin. Results of a double-blind clinical study.
    Loguercio C; Federico A; De Girolamo V; Ferrieri A; Del Vecchio Blanco C
    Minerva Gastroenterol Dietol; 2003 Mar; 49(1):53-62. PubMed ID: 16481971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal hepatic encephalopathy.
    Stewart CA; Smith GE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Dec; 4(12):677-85. PubMed ID: 18043677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management options for minimal hepatic encephalopathy.
    Bajaj JS
    Expert Rev Gastroenterol Hepatol; 2008 Dec; 2(6):785-90. PubMed ID: 19090738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics in the management of hepatic encephalopathy: an evidence-based review.
    Rothenberg ME; Keeffe EB
    Rev Gastroenterol Disord; 2005; 5 Suppl 3():26-35. PubMed ID: 17713457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactulose treatment for hepatic encephalopathy, gastrointestinal symptoms, and health-related quality of life.
    Kalaitzakis E; Björnsson E
    Hepatology; 2007 Sep; 46(3):949-50; author reply 951. PubMed ID: 17879365
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of hepatic encephalopathy in patients with cirrhosis.
    Wright G; Jalan R
    Best Pract Res Clin Gastroenterol; 2007; 21(1):95-110. PubMed ID: 17223499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal hepatic encephalopathy: time to recognise and treat.
    Dhiman RK; Chawla YK
    Trop Gastroenterol; 2008; 29(1):6-12. PubMed ID: 18564660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to dispel myths in the treatment of hepatic encephalopathy?
    Braillon A
    Nat Clin Pract Gastroenterol Hepatol; 2007 Oct; 4(10):E1; author reply E2. PubMed ID: 17909528
    [No Abstract]   [Full Text] [Related]  

  • 19. Review article: bacterial flora and pathogenesis in hepatic encephalopathy.
    Williams R
    Aliment Pharmacol Ther; 2007 Feb; 25 Suppl 1():17-22. PubMed ID: 17295848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Ornithine-l-aspartate in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q; Jiang XH; Zheng MH; Chen YP
    J Gastroenterol Hepatol; 2009 Jan; 24(1):9-14. PubMed ID: 18823442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.